BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 10666807)

  • 1. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans.
    Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):586-90. PubMed ID: 12422606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
    Svecová D; Buchvald J; Oprsalová K; Dolezalová A
    Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):115-22. PubMed ID: 11040493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
    Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy.
    Marangoni A; Sparacino M; Mondardini V; Cavrini F; Storni E; Donati M; Cevenini R; Sambri V
    New Microbiol; 2005 Jan; 28(1):37-43. PubMed ID: 15782625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Criteria for evaluation of immunoblots using Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi sensu stricto for diagnosis of Lyme borreliosis].
    Honegr K; Havlasová J; Gebouský P; Dostál V; Pellantová V; Skrabková Z; Hulínská D
    Epidemiol Mikrobiol Imunol; 2001 Nov; 50(4):147-56. PubMed ID: 11769176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of western-immunoblotting to determine serum IgG-antibodies to antigens of different genotypes of Borrelia--Borrelia burgdorferi sensu stricto, Borrelia afzelii, and Borrelia garinii].
    Anan'eva LP; Nasonova VA; Barskova VG; Stir AS
    Med Parazitol (Mosk); 2002; (2):5-8. PubMed ID: 12214528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four different serological methods for detection of antibodies to Borrelia burgdorferi in erythema migrans.
    Olsson I; von Stedingk LV; Hanson HS; von Stedingk M; Asbrink E; Hovmark A
    Acta Derm Venereol; 1991; 71(2):127-33. PubMed ID: 1675520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of Lyme borreliosis in children.
    Aberer E; Kehldorfer M; Binder B; Schauperi H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B; Glatz M; Kerl H; Müllegger RR
    Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans.
    Zore A; Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Pikelj A; Jurca T; Logar M; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):606-9. PubMed ID: 12422609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Borrelia strains that cause erythema migrans in Alsace, France].
    Antoni-Bach N; Jaulhac B; Hansmann Y; Limbach F; Lipsker D
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):15-8. PubMed ID: 11937923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies against Borrelia afzelli in patients with an early stage of Lyme disease].
    Flisiak I; Chodynicka B
    Wiad Lek; 2001; 54(1-2):19-25. PubMed ID: 11344697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
    Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H
    Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.